← FDA Drug Approvals (Drugs@FDA)
PALIPERIDONE PALMITATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2024-05-20
Drug application
- FDA Application #
ANDA216228- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PALIPERIDONE PALMITATE
- Generic name
- Paliperidone Palmitate
- Active ingredients
- PALIPERIDONE PALMITATE
- Dosage form
- SUSPENSION, EXTENDED RELEASE
- Route
- INJECTABLE
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN PHARMS INC
- First approval
- 2024-05-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown